APOA5 and coronary artery disorder: Kang et al. [30] demonstrated that the C allele carriers had higher levels of apoAV and TG than the non-carriers in type 2 diabetes patients, whereas Jang et al. [31] reported that the C allele carriers had lower levels of apoAV but higher levels of TG in healthy subjects and CHD patients.